JP2022530055A5 - - Google Patents

Info

Publication number
JP2022530055A5
JP2022530055A5 JP2021563030A JP2021563030A JP2022530055A5 JP 2022530055 A5 JP2022530055 A5 JP 2022530055A5 JP 2021563030 A JP2021563030 A JP 2021563030A JP 2021563030 A JP2021563030 A JP 2021563030A JP 2022530055 A5 JP2022530055 A5 JP 2022530055A5
Authority
JP
Japan
Prior art keywords
host cell
amino acid
dna sequence
variant
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021563030A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530055A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029855 external-priority patent/WO2020219908A1/en
Publication of JP2022530055A publication Critical patent/JP2022530055A/ja
Publication of JP2022530055A5 publication Critical patent/JP2022530055A5/ja
Pending legal-status Critical Current

Links

JP2021563030A 2019-04-25 2020-04-24 拡張されたdna標的化範囲を有する操作されたcas9 Pending JP2022530055A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962838498P 2019-04-25 2019-04-25
US62/838,498 2019-04-25
PCT/US2020/029855 WO2020219908A1 (en) 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range

Publications (2)

Publication Number Publication Date
JP2022530055A JP2022530055A (ja) 2022-06-27
JP2022530055A5 true JP2022530055A5 (cg-RX-API-DMAC7.html) 2023-04-20

Family

ID=72941444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563030A Pending JP2022530055A (ja) 2019-04-25 2020-04-24 拡張されたdna標的化範囲を有する操作されたcas9

Country Status (12)

Country Link
US (1) US20220204954A1 (cg-RX-API-DMAC7.html)
EP (1) EP3958914A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022530055A (cg-RX-API-DMAC7.html)
KR (1) KR20220025708A (cg-RX-API-DMAC7.html)
CN (1) CN114206394A (cg-RX-API-DMAC7.html)
AU (1) AU2020261071A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021306A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137903A1 (cg-RX-API-DMAC7.html)
IL (1) IL287541A (cg-RX-API-DMAC7.html)
MX (1) MX2021012966A (cg-RX-API-DMAC7.html)
SG (1) SG11202111814XA (cg-RX-API-DMAC7.html)
WO (1) WO2020219908A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US20230295611A1 (en) * 2022-03-01 2023-09-21 Versitech Limited Cas9 protein for genome editing
CN115083532B (zh) * 2022-06-21 2024-08-27 中国科学技术大学 基于分子动力学模拟获取rsv f突变体的方法
CN115927439B (zh) * 2022-08-29 2026-04-21 中国农业科学院作物科学研究所 CRISPR/SaCas9系统在大豆基因编辑中的应用
AU2024309386A1 (en) 2023-06-30 2025-12-18 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
CN117866926B (zh) * 2024-03-07 2024-08-16 珠海舒桐医疗科技有限公司 一种CRISPR-FrCas9蛋白突变体及应用
WO2025213016A2 (en) 2024-04-04 2025-10-09 Christiana Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016226077B2 (en) * 2015-03-03 2021-12-23 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases with altered PAM specificity
WO2016205759A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
US9512446B1 (en) * 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
KR102569848B1 (ko) * 2016-12-23 2023-08-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Pcsk9의 유전자 편집
JP6628387B2 (ja) * 2017-09-05 2020-01-08 国立大学法人 東京大学 改変されたCas9タンパク質及びその用途

Similar Documents

Publication Publication Date Title
US11946040B2 (en) Adenine DNA base editor variants with reduced off-target RNA editing
JP2019536425A5 (cg-RX-API-DMAC7.html)
Karn et al. Protein structural domains in the Caenorhabditis elegans unc-54 myosin heavy chain gene are not separated by introns.
CN113373130A (zh) Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用
JP2025120176A5 (cg-RX-API-DMAC7.html)
JP2023126956A (ja) 望ましくないオフターゲット塩基エディター脱アミノ化を制限するためのスプリットデアミナーゼの使用
EP4021945A2 (en) Combinatorial adenine and cytosine dna base editors
JP2022526695A (ja) 遺伝子編集における非意図的な変異の阻害
JP2023541400A5 (cg-RX-API-DMAC7.html)
CN107810270A (zh) Crispr杂合dna/rna多核苷酸及使用方法
CA3137903A1 (en) Engineered cas9 with broadened dna targeting range
WO2023232109A1 (zh) 新的crispr基因编辑系统
CN113583999A (zh) Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用
JP2021522825A5 (cg-RX-API-DMAC7.html)
WO2023165613A1 (zh) 5'→3'核酸外切酶在基因编辑系统中的用途和基因编辑系统及其编辑方法
AU2003215094A1 (en) Zinc finger libraries
JP2024501892A (ja) 新規の核酸誘導型ヌクレアーゼ
WO2024156085A1 (en) Mb2cas12a variants with enhanced efficiency
US20220090065A1 (en) Novel tracrRNA system for Cas9
US20260035679A1 (en) Genome editing technique
WO2025010350A2 (en) Compositions and methods for precise genome editing using retrons
JP2026515554A (ja) Crisprの干渉および活性化のための改善された方法および組成物
JP2025535373A5 (cg-RX-API-DMAC7.html)
RU2021134280A (ru) Сконструированный cas9 с расширенным диапазоном направленного воздействия на днк
CN113652411A (zh) Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用